Clinical trial
A Randomised Trial to Compare the Efficacy and Safety of Intranasal Lorazepam and Intramuscular Paraldehyde in the Treatment of Convulsions in Children
NCT00116064 is registered in ClinicalTrials.gov with Kamuzu University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Trial to Compare the Efficacy and Safety of Intranasal Lorazepam and Intramuscular Paraldehyde in the Treatment of Convulsions in Children
- Lead sponsor
- Kamuzu University of Health Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- June 30, 2005
- Enrollment
- 156
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
convulsions, status epilepticus